Canada markets closed

MaaT Pharma SA (4RD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
6.54+0.18 (+2.83%)
At close: 03:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 95.72M
Enterprise Value 85.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)33.36
Price/Book (mrq)4.43
Enterprise Value/Revenue 38.37
Enterprise Value/EBITDA -7.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 3-10.16%
S&P500 52-Week Change 326.24%
52 Week High 39.92
52 Week Low 34.78
50-Day Moving Average 37.98
200-Day Moving Average 37.08

Share Statistics

Avg Vol (3 month) 32
Avg Vol (10 day) 3N/A
Shares Outstanding 513.87M
Implied Shares Outstanding 614.64M
Float 82.97M
% Held by Insiders 127.05%
% Held by Institutions 149.26%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,342.12%

Management Effectiveness

Return on Assets (ttm)-28.44%
Return on Equity (ttm)-83.41%

Income Statement

Revenue (ttm)2.23M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)-9.20%
Gross Profit (ttm)N/A
EBITDA -19.74M
Net Income Avi to Common (ttm)-19.72M
Diluted EPS (ttm)-1.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.31M
Total Cash Per Share (mrq)2.1
Total Debt (mrq)14.07M
Total Debt/Equity (mrq)68.77%
Current Ratio (mrq)2.78
Book Value Per Share (mrq)1.77

Cash Flow Statement

Operating Cash Flow (ttm)-18.67M
Levered Free Cash Flow (ttm)-11.1M